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Abstract
Weight control diets favorably affect parameters of the metabolic syndrome and delay the onset of diabetic complications.
The adaptations occurring in adipose tissue (AT) are likely to have a profound impact on the whole body response as AT is a
key target of dietary intervention. Identification of environmental and individual factors controlling AT adaptation is
therefore essential. Here, expression of 271 transcripts, selected for regulation according to obesity and weight changes,
was determined in 515 individuals before, after 8-week low-calorie diet-induced weight loss, and after 26-week ad libitum
weight maintenance diets. For 175 genes, opposite regulation was observed during calorie restriction and weight
maintenance phases, independently of variations in body weight. Metabolism and immunity genes showed inverse profiles.
During the dietary intervention, network-based analyses revealed strong interconnection between expression of genes
involved in de novo lipogenesis and components of the metabolic syndrome. Sex had a marked influence on AT expression
of 88 transcripts, which persisted during the entire dietary intervention and after control for fat mass. In women, the
influence of body mass index on expression of a subset of genes persisted during the dietary intervention. Twenty-two
genes revealed a metabolic syndrome signature common to men and women. Genetic control of AT gene expression by cis
signals was observed for 46 genes. Dietary intervention, sex, and cis genetic variants independently controlled AT gene
expression. These analyses help understanding the relative importance of environmental and individual factors that control
the expression of human AT genes and therefore may foster strategies aimed at improving AT function in metabolic
diseases.
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Introduction
Obesity is characterized by an excess of fat deposited in adipose
tissue (AT) as triglycerides. An increase in adiposity is associated
with increased risk of cardiovascular disorders and metabolic
abnormalities, including hypertension, insulin resistance, type 2
diabetes, obstructive sleep apnea and cancers. Diet-induced weight
loss prevents risk for type 2 diabetes and metabolic syndrome
[1,2], emphasizing the pivotal role of AT in obesity-related
complications. As a key target tissue of dietary intervention and a
node of integration between metabolism and immunity, adapta-
tions occurring in AT are likely to have a profound impact on the
whole body response [3,4].
Obesity is a complex disorder with numerous contributing
environmental and genetic factors. A multidisciplinary research
effort involving a combination of clinical, biochemical and omics
approaches appears mandatory to increase knowledge in the
complexity of biological traits and processes associated with
obesity [5]. Through probing of the transcriptional activity of
tissues, the techniques allowing systematic analysis of AT gene
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expression have proved useful at identifying master genes [6] and
regulatory networks involved in human obesity and related
disorders [7]. Moreover, mRNAs are molecular species easily
and evenly amplified. Hence, mRNA profiling remains one of the
most powerful methods to comprehensively explore minute
amounts of tissue. Real-time PCR, which provides great dynamic
range and sensitivity, is a low throughput and time-consuming
technology. DNA microarray analysis allows genome-wide profil-
ing often applied to small subsets of samples. Combining benefits
of both approaches recently became possible through the
emergence of microfluidic-based technologies that use very limited
sample and reagent quantities [8]. Moreover, large-scale investi-
gation of gene expression in small AT samples obtained from
microbiopsy has been impaired by poor yield of total RNA due to
the richness in lipid. Optimization of AT biopsy handling and total
RNA extraction is thus an essential step to profitably use AT
samples for gene profiling applications.
The DiOGenes trial is one of the largest longitudinal dietary
interventions worldwide consisting in an 8-week weight loss diet and
a 26-week weight control phase with different dietary regimes
[9,10]. The prospective long-term, randomized, controlled study
design offered a unique opportunity to apply genomics technology
to dietary intervention aimed at maintaining weight loss. In this
study, we applied an improved total RNA preparation from AT to
the thousands of samples available during the DiOGenes study.
Using a novel microfluidic technology, quantitative expression
analysis of AT genes was performed in individuals from this cohort.
The relationship between mRNA levels and bio-clinical and genetic
data was investigated. These integrative analyses provide evidence
of composite control of AT gene expression by nutrition, metabolic
syndrome, body mass index (BMI), sex and genotype.
Results
Optimization of total RNA extraction and gene
expression normalization in human adipose tissue
Despite recent development in single-step techniques dedicated
to lipid-enriched samples, total RNA extraction from AT had to
be improved before application to AT analysis in the DiOGenes
clinical trial. Each step of total RNA extraction from small
amounts of human AT samples was optimized in order to prevent
the loss of precious samples (Table S1, Figure S1). In the context of
large scale clinical programs, we also investigated whether long
term storage of fat samples may have negative impact on total
RNA integrity. AT samples frozen in liquid nitrogen can be stored
at 280uC up to 3 years without affecting total RNA yield (Figure
S1) or quality (data not shown). Flash freezing in liquid nitrogen
before storage proves as efficient as soaking the samples in
preservative solutions. This is a critical point as it allows use of fat
samples for other applications than transcriptomics. Different
approaches were used for real time qPCR data normalization. Use
of the simple 22DCt method with GUSB as a reference transcript
proved to be the best for normalization in human subcutaneous
AT (Figure S2).
DiOGenes study
The DiOGenes dietary intervention consisted of two phases
[9,10]. The first phase was an 8-week low-calorie diet (LCD) with
the objective of $8% weight loss. In the second phase, the
successful patients were randomized into one of five ad libitum
weight maintenance diets (WMD): four diets combining high and
low protein content with high and low glycemic index of
carbohydrates and a control diet according to National dietary
guidelines on healthy diets. Clinical investigations including
subcutaneous AT microbiopsies were performed before and at
the end of each phase.
Five hundred sixty eight obese individuals, age 24 to 63 (mean
weight: 99.6617.1 kg) had clinical data available and good quality
AT RNA samples. Two groups of patients were defined (Figure
S3). The first group, group A, included 311 obese individuals (107
men and 204 women) with gene expression data available at each
clinical investigation day. The second, group B, had 204
individuals with gene expression data available at baseline and
after LCD. Subjects were also categorized according to the
occurrence of metabolic syndrome at baseline [11]. Group A had
125 metabolic syndrome and 186 non-metabolic syndrome
individuals at baseline. Group B had 81 metabolic syndrome
and 123 non-metabolic syndrome individuals at baseline. All
baseline anthropometric and plasma characteristics are described
in Table S2. In both men and women, blood pressure,
triglycerides, HDL-cholesterol, C reactive protein, adiponectin,
fasting glucose and insulin were significantly different in metabolic
syndrome compared to non-metabolic syndrome individuals. In
addition, women with metabolic syndrome had higher weight,
BMI, fat mass and waist circumference.
Adipose tissue gene expression is regulated during the
different phases of the DiOGenes dietary program
Massive parallel reverse transcription quantitative PCR (RT-
qPCR) was performed on AT from the DiOGenes study using a
microfluidic qPCR device [8]. AT expression data from 271 genes
of interest (Table S3) was investigated on 1341 samples from 515
subjects. The genes were selected from our previous published and
unpublished DNA microarray analyses on a limited number of
individuals. The choice was made using the following criteria:
regulation during dietary weight loss programs [12–14], including
the DiOGenes trial [14], and differential expression according to
the presence or absence of obesity and metabolic syndrome
[15,16]. Forty percent of these genes encoded proteins involved in
metabolism and 23% participated in immune response. This list
encompassed 38 AT macrophage [15,16] and 84 adipocyte
Author Summary
In obesity, an excess of adipose tissue is associated with
dyslipidemia and diabetic complications. Gene expression
is under the control of various genetic and environmental
factors. As a central organ for the control of metabolic
disturbances in conditions of both weight gain and loss, a
comprehensive understanding of the control of adipose
tissue gene expression is of paramount interest. We
analyzed adipose tissue gene expression in obese individ-
uals from the DiOGenes protocol, one of the largest dietary
interventions worldwide. We found evidence for compos-
ite control of adipose tissue gene expression by nutrition,
metabolic syndrome, body mass index, sex, and genotype
with two main novel features. First, we observed a
preeminent effect of sex on adipose tissue gene expres-
sion, which was independent of nutritional status, fat
mass, and sex chromosomes. Second, the control of gene
expression by cis genetic factors was unaffected by sex
and nutritional status. Altogether, the effects of the
investigated factors were most often independent of each
other. Comprehension of the relative importance of
environmental and individual factors that control the
expression of human adipose tissue genes may help
deciphering strategies aimed at controlling adipose tissue
function during metabolic disorders.
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markers [12,15], i.e. genes expressed in these cell types at much
higher levels than in any other AT cell type.
Controlling for weight variation, a majority of genes were
regulated in both men and women by the dietary weight
management program. The main pattern observed on 175 genes
was an opposite regulation of AT gene expression between LCD
and WMD phases (Figure 1, Table S4). Genes downregulated
during LCD and upregulated during WMD (n=158) were mostly
associated with metabolic functions (n=110), including 72 genes
defined as adipocyte markers. The top ranking genes included
SCD, FADS1 and FADS2 encoding enzymes involved in unsatu-
rated fatty acid synthesis. An inverse trend was seen for 17 genes
including 9 immunity-related genes. Four of those genes were AT
macrophage markers. Most of the genes had similar expression at
the end of the intervention compared to baseline. Forty three
genes showed variations in expression at the end of WMD
compared to baseline (Table S5). The majority showed decreased
expression compared to baseline. LEP showed a downregulation
during calorie restriction that persisted until the end of the
intervention. As shown in Figure 1, this pattern is superimposable
with the evolution of HOMA-IR, an index of insulin resistance.
The macronutrient composition of the diet during the WMD
phase had no effect on AT gene expression. We also looked at
genes related to weight changes during the ad libitum WMD by
comparing changes in mRNA levels between the end of LCD and
the end of WMD in women who lost and those who regained at
least 50% of the weight lost during calorie restriction. The changes
in mRNA levels of 16 genes differed between the two groups of
women (Table S6). CIDEA which is involved in fat cell lipid droplet
metabolism was the best marker for weight loss (Figure 2). FADS1,
encoding a fatty acid desaturase, and BCAT1, encoding a
branched-chain amino acid aminotransferase, were the best
markers for weight regain.
Figure 1. Most remarkable profiles of adipose tissue gene expression during a dietary weight loss program. Adipose tissue gene
expression was assessed at baseline (BAS) and during a dietary trial including an 8 week low calorie diet (LCD) followed by a 26 week weight
maintenance diet (WMD) (men, black squares n= 107; women, open squares n=204). ({) Comparison between BAS and end of LCD, P,0.05
according to linear mixed effect model ran separately for men and women. (*) Comparison between end of LCD and end of WMD, P,0.05 according
to linear mixed effect model ran separately for men and women. (#) Comparison between BAS and end of WMD, P,0.05 according to linear mixed
effect model ran separately for men and women. The evolution of the insulin resistance index HOMA-IR in the entire population is shown as black
circles for comparison with leptin mRNA levels. Error bars represent S.E.M.
doi:10.1371/journal.pgen.1002959.g001
Figure 2. Adipose tissue markers of weight regain and weight
loss during the 26-week weight maintenance diet. Changes in
mRNA levels between the end of low calorie diet and the end of the 26
week weight maintenance diet were compared in women regaining
(open bars n=31) or losing (black bars n=29) weight.
doi:10.1371/journal.pgen.1002959.g002
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Sex, metabolic syndrome, and obesity impact adipose
tissue gene expression
Principal component analysis of gene expression data from
group A and group B subjects at baseline indicated that the major
component explaining AT gene expression data distribution was
sex. Figure S4a depicts partial least square-discriminant analysis of
AT genes with sex specificity. To list the AT genes with sex-biased
expression, a mixture model controlling for centre was first built
with data from group A. One hundred and eighty six genes
exhibited sex specificity. The same model was then run with data
from group B, giving a list of 158 genes. Sex specificity for 109
transcripts persisted during the dietary intervention (Table S7).
Higher expression in female AT was found for all genes except for
CCL19, which showed higher expression in male AT (Figure 3).
Fat mass being higher in women than in men could possibly
explain this marked sexual dimorphism. However, 88 genes
remained different when controlling for fat mass. Only 5 genes
were located on sex chromosomes (Table S7). SAA4, AZGP1,
CDKN2C and CES1 were the highest ranked genes with a more
than two-fold higher expression level in female than in male AT
(Figure 3).
Exploratory analysis of AT gene expression also indicated a
discriminatory effect according to the presence or absence of
metabolic syndrome (Figure S4b). Because the clinical presenta-
tion of metabolic syndrome is different in men and women and
might be at least in part originating in the AT [16,17], we
separately analysed the 2 populations to assess the molecular
characteristics of AT from patients with metabolic syndrome. A
metabolic syndrome signature was found for 22 genes (Table S8).
CCL3 and AZGP1 showed two-fold higher and lower expression,
respectively, in women with metabolic syndrome compared to
women without metabolic syndrome (Figure 4). The difference,
albeit less pronounced, was also present in men.
To assess the contribution of obesity to AT gene expression, the
impact of BMI was studied in men and women separately at
baseline and along the dietary intervention. In women, 51 genes
showed significant BMI dependency that persisted during the
whole dietary intervention (Table S9). In men, a single gene,
AZGP1, was dependent on BMI at each time point of the
intervention (data not shown).
Human adipose tissue functional interconnections
To elucidate the relationship between AT gene expression and
related phenotypes at a greater depth, we used a co-correlation
network-based approach. Interactions between the two matching
bio-clinical and AT gene expression data sets were modeled using
partial correlations. By eliminating over-estimation of co-correla-
tions due to correlation with a third variable, partial correlations
measure direct correlation between two variables with control for
confounding variables. First, in addition to bio-clinical parameters
(Table S2), we selected 38 metabolism and immunity related genes
that showed regulation in the present analysis (Table S10). Since
sex appeared to control AT gene expression variance more than
other parameters, we used the network approach on the 180 men
and 335 women separately. Figure S5 displays the regulatory
networks in men and women. Edges represent direct and strong
correlations and thickness connection strength between variables.
Each node represents a variable. Node degree refers to the number
of edges attached to the node. High degree indicates hubs which
are the most connected variables. Betweenness centrality quanti-
fies the importance of a variable within network. Nodes with
highest betweenness centrality are those providing the strongest
network connection and show key variables in the network. The
topology of the male and female networks was similar with 75% of
edges in common between men and women. A majority of highly
connected co-expression networks consisted of the same clinical
parameters and genes that clustered together in both men and
women. Several macrophage markers (Table S3) showed strong
connection. A module consisting of the same group of correlated
genes in both the male and female networks encompassed genes
involved in de novo lipogenesis such as FASN, SCD, FADS1, FADS2
and ELOVL5. In men and women, CIDEA and AZGP1, two
cachexia markers, were connected. Next, the network-based
approach was used on 204 women from group A (Table S2) to
expand the analyses to functional interconnections during the
dietary intervention. The list of genes consisted of the lipogenesis
module observed at baseline (Figure S5) extended to related
glycolysis and glucose metabolism genes (Table S11). Networks
were built during LCD (Figure 5a) and from baseline to the end of
the WMD (Figure 5b).The two data-driven dependency networks
Figure 3. Sexual dimorphism of adipose tissue gene expres-
sion. Men, open bars (n=180). Women, black bars (n= 323). Most
representative adipose tissue genes are shown (See Table S7). Error bars
represent S.E.M.
doi:10.1371/journal.pgen.1002959.g003
Figure 4. Differential adipose tissue gene expression in obese
individuals according to the presence of metabolic syndrome.
Adipose tissue gene expression in obese individuals with (black bars
n= 206) and without (open bars n= 309) the metabolic syndrome (see
Table S8). Error bars represent S.E.M.
doi:10.1371/journal.pgen.1002959.g004
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in AT showed 62% of shared edges. HK1 appeared as an
important hub, with 10 connections, including another hub, SCD,
ACACB, ELOVL5 and fasting glucose (Figure 5a). Notably, two
components of the metabolic syndrome, waist and triglycerides,
were highly connected to the most important node, SCD, which
was also highly connected to glycolytic genes (SLC2A4 and PCK1)
during LCD. From baseline to the end of the WMD (Figure 5b),
fat mass, waist and triglycerides were associated with the network
key node ALDOC, which was connected to several lipogenic genes
(FASN, ACACB, SCD, FADS2 and ELOVL5).
Human adipose tissue gene expression is under genetic
control by cis signals
We identified 2953 single nucleotide polymorphisms (SNPs)
which were in the close proximity of 252 genes. At baseline, 118
SNPs representing 46 genes showed association with AT gene
expression (Table S12). The strongest associations (P,10210) were
found for ALDOB, MARCO, MMP9 and HLA-A (Figure 6). Four
SNPs located in the intronic regions ofMARCO, which encodes an
AT macrophage-specific marker regulated by obesity [15] and
dietary intervention (Table S5), showed associations with
P,10220. A moderate effect of sex and BMI was observed for 3
and 13 SNPs, respectively. However, these effects were not
consistent among SNPs with significant associations with AT gene
expression in the corresponding genes. The majority of the
associations observed at baseline remained significant when
expression after LCD and WMD were considered (Table S13).
Of note, no SNP showed association with diet-induced variations
in mRNA levels (P.0.5).
Discussion
Carefully monitored weight-control diets favorably affect
parameters of the metabolic syndrome and delay the onset of
diabetic complications [1]. AT is a key player in the homeostatic
control of whole body metabolism. Besides the more recent DNA
methylome and microRNA arrays, gene expression profiling is one
of the most comprehensive omics technologies, which permits
parallel quantitative measurements of a large number of targets.
However, a minimal amount of high quality total RNA is
required. To study large intervention programs, we optimized the
entire process, from needle biopsy of human subcutaneous AT to
long term storage of samples. A single needle biopsy allows fast
and painless AT sampling that may be easier to perform than
blood sampling in morbidly obese subjects. Biopsies of about
200 mg are easily obtained in large scale intervention studies and
can also be obtained from lean individuals. From this amount of
tissue up to 34,100 different transcripts can be quantified using the
Fluidigm Biomark Dynamic Array technology. This high-through-
put technology has been successfully applied to many biological
fields [18–20]. It allows reduction in cost and time, and
improvement of accuracy, throughput and performance compared
with conventional instruments. We show here its potencies to
study AT expression of multiple genes in large-scale population-
based interventions. Normalization is an essential step to correct
for systematic bias in transcriptomic data. In microfluidic RT-
qPCR assays, systematic errors due to sampling, reverse
transcription and preamplification steps as well as set and plate
spreading must be eliminated. Numerous different methods can be
used for data normalization, including those used for transcrip-
tome analyses [21]. When analyzing real-time PCR data, the most
widely used is the 22DCt method using a reference gene [22]. The
ideal reference, also referred to as a house-keeping gene, should be
constantly transcribed in all cell types and tissues regardless of
internal and external influences. However, the expression of
house-keeping genes may vary considerably. GAPDH is one of the
most commonly used house-keeping genes. However, GAPDH
expression was shown to be regulated during dietary intervention
Figure 5. Dependency networks and dietary intervention. Two dependency networks were constructed from selected bio-clinical data and
gene expression from the lipogenic module. Each node is a gene or a bio-clinical parameter. Node degree is indicated with size. Node color indicate
betweenness centrality measure that counts how often a node appears on shortest paths between two other nodes in the network; red nodes are
variables with high betweenness and green nodes are variables with low betweenness. Betweenness centrality indicates nodes that are the most
likely to disconnect network if removed. The variables are connected by an edge only if their partial correlation is significantly nonzero. Edge
thickness is proportional to the strength of correlation. Edge color indicates correlation from the most positive (red) to the negative (green). (a)
Dependency network of changes from baseline to the end of the low calorie diet. (b) Dependency network of changes from baseline to the end of
the weight maintenance diet.
doi:10.1371/journal.pgen.1002959.g005
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in this study and previous work [12]. The ribosomal 18S is another
common reference gene. However, because of its very high
expression level, this transcript shows such a strong expression
after the preamplification step that it overflows the detection
system. Here, the use of GUSB as a reference gene in the easy-to-
use 22DCt method proved to deliver the best normalization for
human subcutaneous AT.
AT gene expression profiling combined with clinical investiga-
tions has opened a novel approach to decipher physiological and
pathophysiological processes [5]. Most previous studies have
aimed at comparing obese and lean individuals and observing
the effects of altered body weight during dynamic weight change.
The highly clinically relevant weight stabilization phase has rarely
been studied. We have previously investigated AT gene expression
during multiple phase dietary interventions on a limited number of
individuals [12]. The DiOGenes intervention study was designed
to investigate diet-induced changes on a much larger scale [10].
This trial focused on identifying key dietary and genetic factors as
a basis for predicting whether individuals may reach and maintain
healthy weight. The number of participants and the complete
bioclinical characterization combined with AT biopsy offered a
unique opportunity to study the interactions between sex,
metabolic status, dietary phases and genetic factors. Unexpectedly,
a striking sex effect on AT gene expression that persisted during
the dietary intervention for most of the sex-specific genes was
found. As a prototypical example, it has repeatedly been shown
that leptin AT mRNA level is higher in females than in males even
after correction for the degree of body fat mass [23]. Similar sexual
dimorphism has previously been reported for 45 of the genes
described in the present study in mouse AT [24]. Higher
expression in female than in male AT was found for all but 1
gene. However, to ascertain that the majority of human AT genes
showing sex differences have female-biased expression, a system-
atic analysis would be required. Higher fat mass in women than in
men could possibly explain this marked sexual dimorphism.
However, 80% of the genes remained different when controlling
for fat mass. Indeed, SAA4 and CDKN2C AT expression are
increased and decreased, respectively, in morbidly obese subjects
whereas the two genes show higher expression in women than men
[25,26]. The contribution of gonadal hormones and sex chromo-
somes has been investigated in mouse models. Sexual steroids play
a strong role in sex-biased gene expression in various tissues with
minor sex differences explained by direct effects of the sex
chromosome in liver genes [27]. Here, less than 5% of the human
AT sex-related genes were located on sex chromosomes. The large
number of subjects with a wide range of adiposity allowed testing
the effect of BMI on AT gene expression at baseline and during
the dietary intervention. In women, 51 genes show BMI
Figure 6. Adipose tissue gene expression according to genotype distribution of cis signals. Most representative adipose tissue genes are
shown (see Table S12). Error bars represent S.E.M.
doi:10.1371/journal.pgen.1002959.g006
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dependency which persists at each time point of the dietary
intervention indicating adiposity-dependent control of gene
expression that is not influenced by diet-induced changes in
weight. AZGP1 was the only common gene to men and women
and among the top ranking less expressed genes in the morbidly
obese patients (BMI.40). It was recently shown as down regulated
with fat mass expansion in obesity in both visceral and
subcutaneous fat with positive association with adiponectin [28].
Of note, the network approach also showed such connection in the
male network. The lower number of significant genes in men may
be related to real sex differences but may also be due to the lower
number of men in the cohort. A metabolic syndrome signature was
also found in AT. As a top ranking gene, CCL3 encodes
macrophage inflammatory protein 1a, a CC chemokine involved
in the interactions between immune cells and regulated by insulin
resistance in AT [29]. AZGP1 appears as a marker of sexual
dimorphism, obesity and metabolic syndrome encodes an
adipokine with putative antidiabetic properties [30].
When looking along the DiOGenes dietary program, the main
pattern was an opposite regulation of AT gene expression
between LCD and WMD phases. Genes downregulated during
LCD and upregulated during WMD were mostly adipocyte genes
associated with metabolic functions [12]. The top ranking genes
encoded enzymes involved in fatty acid desaturation [31]. An
inverse trend was seen for immunity-related genes. As a result of
the opposite regulation between LCD and WMD, most of the
genes had similar expression at the end of the intervention
compared to baseline. However, a subset of genes showed
downregulation at the end of the dietary intervention. The list
included several genes previously characterized as human AT
macrophage-specific markers (CD68, CD163, CD209, IL10, LIPA,
MARCO, MS4A4A, PLA2G7, SPP1) [12,15]. This coordinated
downregulation most likely reflects a decrease in AT macrophage
number as observed in a 6-month weight reducing intervention
[32]. Leptin mRNA levels were also lower at the end of the
dietary intervention. The superimposition of LEP and HOMA-IR
data lend support to our hypothesis that variation in LEP
expression contributes to the improvement in insulin sensitivity
observed during diet-induced weight loss [3].
Genes related to weight changes during WMD include
AGPAT9, presumably involved in the biosynthesis of triacylglycerol
and phospholipid, ALOX12, encoding the arachidonate12-lipoxy-
genase involved in production of inflammatory and adipogenesis
mediators, and the proangiogenic VEGFA, which all showed
robust overexpression in individuals who regained weight. PKM2,
AP2M1, ACTR3 and CES1 had been shown in microarray
experiments to have higher expression in individuals who failed
to control their weight [14]. FADS1, encoding a fatty acid
desaturase, and BCAT1, encoding a branched-chain amino acid
aminotransferase, were the best markers for weight regain.
Interestingly, branched-chain amino acid catabolism is down-
regulated in obese individuals [33]. CIDEA, which plays a critical
role in fat cell lipid droplet metabolism [34], showed decreased
expression in individuals continuing to lose weight after LCD,
supporting a role for the encoded protein in the adaptation of
subcutaneous AT to body weight changes as over-feeding-induced
weight gain induces its expression [35]. The macronutrient
composition of the diet (i.e., protein content and glycemic index)
during the WMD phase had no effect on AT gene expression in
agreement with previous data on energy-restricted diets differing
in fat and carbohydrate content [13]. Therefore, during dietary
weight management programs, energy balance and fat mass
variations rather than the composition of the diet is a determinant
of AT gene expression.
During LCD, network analysis of gene expression and clinical
parameters showed that the top associations function as part of a
major hub gene, the stearoyl CoA desaturase SCD, which is highly
connected to components of the metabolic syndrome and the gene
encoding a glycolytic enzyme, hexokinase HK1, connected to
glycemia. These genes are targets of ChREBP, a transcription
factor involved in glucose-mediated control of de novo lipogenesis
gene expression [36,37]. These connections suggest that ChREBP
target genes are regulated during LCD. This transcription factor
was not studied here. The link between ChREBP and metabolic
improvements along the dietary intervention requires further
investigation [38]. Along the dietary intervention, clinical data and
gene co-expression network analysis also revealed ALDOC, an
aldolase involved in glycolysis, and fat mass as key nodes. Both
hubs were connected to components of the metabolic syndrome.
The ALDOC-centered module included key genes for de novo
lipogenesis, illustrating the common transcriptional control of
glycolysis and fatty acid synthesis [37]. The fat mass centered
module was composed of glycolytic genes, indicating a direct link
between change in fat mass and aerobic glycolysis, which seems to
be related to the connection between de novo lipogenesis gene
expression and metabolic features [39].
Human AT gene expression is under strong genetic control
[40]. Recent genome-wide gene expression and genotyping
analysis identified 10,000 cis SNPs associated to gene expression
in subcutaneous AT [41]. The number of cis expression SNPs
(eSNPs) was much higher than the number of trans eSNPs. In the
present study, more than 80% of the genes with eSNPs had not
previously been reported [41]. This high level of detection was
related to several factors. First, we selected SNPs located in the
immediate vicinity of the genes that allow capture of significant
associations with our sample size [42]. Second, we investigated a
carefully selected population enrolled in a multicentric dietary
intervention [9,10]. Thereby, we could control for biological and
non-biological confounders such as center, sex, fat mass and diet.
Highly significant associations were found forMARCO andMMP9.
MARCO encodes a class A scavenger receptor shown to be specific
of AT macrophages compared to other human AT cell types [15].
AT macrophages also specifically produce metalloproteinase 9, a
key enzyme involved in remodeling processes [43]. Of 46 genes
with eSNPs, 19 were directly related to immunity and inflamma-
tion and were highly expressed in human AT, in agreement with
the existence of an AT macrophage gene network module with
tight cis genetic control [40]. Strikingly, the eSNPs identified here
were not influenced by sex and diet-induced changes in AT gene
expression. We found no evidence of association between cis SNPs
and variations in mRNA levels during the dietary protocol,
suggesting that cis genetic control operates at baseline and is
preserved during the dietary intervention but does not influence
the response to the diet.
As prototypical examples, ACSL1, ECHDC3 and HSDL2 mRNA
levels were influenced by all the investigated factors (Figure 7).
SNPs did show associations with AT mRNA levels as transcript
abundance varied during the dietary intervention. It also differed
according to sex and metabolic syndrome. Dietary intervention
did not alter the sexual dimorphism in gene expression. ACSL1,
which catalyzes the conversion of long chain fatty acids into acyl-
CoAs, is the most abundant ACSL isoform expressed in AT. AT-
specific ablation of Acsl1 in mice shows that the enzyme plays a
crucial role in directing acyl-CoAs towards b-oxidation in fat cells
[44]. Here, ACSL1 gene expression was lower in individuals with
metabolic syndrome. An association between ACSL1 gene
polymorphisms and the metabolic syndrome has recently been
reported [45]. These data suggest that impaired adipocyte fatty
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acid oxidation due to ACSL1 defect may constitute a feature of the
metabolic syndrome.
The present data provide evidence for control of AT gene
expression by nutrition, sex, metabolic status and genotype. A main
feature was a major effect of sex, which was independent of sex
chromosomes, fat mass and dietary intervention. Another charac-
teristic was that the control of gene expression by genetic elements
appeared unaffected by nutritional status. Altogether, the effects of
the investigated factors were most often independent of each other.
Understanding the relative importance of environmental and
individual factors that control the expression of human AT genes
may help in deciphering strategies aimed at improving AT function
in metabolic diseases.
Methods
Human subcutaneous adipose tissue sampling
Fat samples used for the optimization of total RNA
extraction were obtained using abdominal dermolipectomy
from the plastic surgery department of the Toulouse University
Figure 7. Most representative adipose tissue gene expression profiles according to dietary intervention, sex, and metabolic
syndrome. ACSL1, ECHDC3 and HSDL2 adipose tissue gene expression according to dietary intervention (BAS, baseline; LCD, low calorie diet; WMD,
weight maintenance diet), sex and metabolic syndrome (presence, black circles; absence, open circles) in 311 obese individuals. ({) Comparison
between BAS and end of LCD, P,0.05 according to linear mixed effect model ran separately for men and women. (*) Comparison between end of
LCD and end of WMD, P,0.05 according to linear mixed effect model ran separately for men and women. (#) Comparison between BAS and end of
WMD, P,0.05 according to linear mixed effect model ran separately for men and women. Error bars represent S.E.M.
doi:10.1371/journal.pgen.1002959.g007
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Hospitals. The patients were not included in a weight reduction
program.
DiOGenes was registered in ClinicalTrials.gov (NCT00
390637). Briefly, 932 overweight and obese adults in 8 European
centers participated in a dietary program with a 8-week 3.3 MJ/
day LCD (Modifast, Nutrition et Sante´, France). Subjects
achieving 8% of initial body weight loss were randomized to a
6-month ad libitum WMD consisting in one of four low-fat diets
that differed in glycemic index and protein content, or a control
diet as described in [9]. Abdominal subcutaneous AT biopsies
from the DiOGenes protocol were obtained by needle aspiration
under local anesthesia after an overnight fast at baseline, at the end
of LCD and at the end of WMD [14]. All clinical investigations
were performed according to standard operating procedures.
Analysis of blood samples was performed at the Department of
Clinical Biochemistry, Gentofte University Hospital, Denmark as
described in [9].
The study was performed according to the latest version of the
Declaration of Helsinki and the Current International Conference
on Harmonization (ICH) guidelines. All subjects gave verbal and
written informed consent. Applications were submitted to the
regional Ethics Committees from the participating centres and the
study was not undertaken without a positive statement from the
committee regarding the study.
Optimization of total RNA extraction
Five single-step methods for total RNA extraction were
evaluated on 6 human subcutaneous AT samples (Table S1).
Among the 5 extraction methods, 2 yielded very few or partly
degraded total RNA and one low purity RNA. The QIAGEN
methods (RNeasy Mini and RNeasy Lipid Tissue Mini) yielded
sufficient amount of good quality total RNA that appeared to be
free of genomic DNA contamination. Based on the QIAGEN
RNeasy Lipid Tissue Mini Kit, an in-house optimized total RNA
preparation protocol that uses chloroform delipidation and
phenol/guanidine isothiocyanate-based (QIAzol) extraction, sili-
ca-gel membrane purification and microspin technology was set
up (see below). This adapted protocol provided a higher mean
total RNA supply with more consistent yield than other methods.
Adipose tissue sampling and storage conditions
Human AT samples of weights ranging from 0.04 g to 1.5 g
were collected, flash frozen in liquid nitrogen and stored at
280uC. Figure S1a was drawn from 84 AT samples. It shows a
positive correlation between the amount of total RNA extracted
and the weight of the fat biopsies up to 0.2 g. Above 0.5 g of fat,
the amount of total RNA per g of tissue becomes more variable.
The data reveal that 0.3 to 0.5 g of fat are enough for substantial
total RNA recovery. Such an amount may yield a minimum of
5 mg of total RNA which is sufficient for both microarray
application and RT-qPCR. Besides sample preparation, storage
conditions are a major concern because of the instability of mRNA
due to contaminating RNases. In order to prevent total RNA
degradation, commercial RNA stabilization reagents are available.
Figure S1b shows adipose tissue total RNA yield and quality using
alternative protocols. Samples of about 0.5 g of human fat tissue
were collected and stored at 280uC following 5 different
protocols: 1) immediate storage of the freshly cleaned fat sample
at280uC 2) flash-frozen in liquid nitrogen and stored at280uC 3)
stored overnight in RNAlater RNA Stabilization Reagent
(QIAGEN) at 2–8uC, then removed from the RNAlater and
stored at 280uC 4) freshly cleaned fat sample stored at 280uC in
QIAzol Lysis Reagent (QIAGEN) 5) homogenized in QIAzol Lysis
Reagent with ultra-turax homogenizer and stored at 280uC.
These samples were extracted after short term, 1 month, and after
long term, 1 year, storage. The 5 protocols gave similar total RNA
yield and quality.
In-house total RNA extraction protocol
The frozen AT sample was homogenized in QIAzol (QIAGEN)
(2.5 ml of QIAzol for 500 mg of tissue, 5 ml for 1 g of tissue, 1 ml
for #200 mg of tissue) using a rotor-stator homogenizer until
homogeneity (20–40 s; longer time may lead to overheating) then
incubated at room temperature for 5 min. Two hundred ml of
chloroform was added for 1 ml of QIAzol (otherwise the volume of
chloroform was adjusted to QIAzol volume with a 1:5 ratio) and
vigorously shaked for 15 s using a vortex then incubated at room
temperature for 3 min. After centrifugation at 4000 rpm for
15 min at 4uC the upper aqueous phase was transferred to a new
tube. One volume of 70% ethanol was added and mixed by
vortexing. Seven hundred ml of this sample was pipetted onto an
RNeasy Mini Spin Column (QIAGEN) in a 2 ml tube and
centrifuged at $10,000 rpm for 15 s at 25uC. Flow-through was
discarded. This step was repeated using the reminder of the
sample. Seven hundred ml of Buffer RW1 (QIAGEN) was added to
the column and centrifuged at $10,000 rpm for 15 s at 25uC.
Flow-through was discarded. The column was transferred into a
new 2 ml tube. Five hundred ml of Buffer RPE (QIAGEN) was
added to the column and centrifuged at $10,000 rpm for 15 s at
25uC. Flow-through was discarded. Another 500 ml of Buffer RPE
was added to the column and centrifuged at $10,000 rpm for
2 min at 25uC. The column was transferred into a new 2 ml tube
and centrifuged at $10,000 rpm for 1 min at 25uC. To elute, the
RNeasy Mini Spin Column was transferred to a 1.5 ml tube and
30 ml of preheated RNAase-free water at 50uC directly pipetted
onto the column then centrifuged at $10,000 rpm for 1 min at
25uC.
Total RNA quality check
For the optimization of total RNA extraction from AT samples
(Table S1), total RNA quality was checked using ethidium
bromide-stained agarose gels. Concentration was determined
using a Nanodrop spectrophotometer, Illkirch, France). For AT
biopsies from the dietary program, total RNA concentration and
quality were estimated by capillary electrophoresis using the
Experion analyzer (BioRad, Marnes-la-Coquette, France). The
amount of total RNA from the DiOGenes study was
25.369.3 mg/g of AT (n=1363) validating the RNA extraction
and purification method in a large multicenter study. Total RNA
was of good quality and free of genomic DNA.
RT–quantitative PCR using BioMark System
Specific target amplification. cDNA was prepared as
previously described [46] from 200 ng or 500 ng of total RNA,
depending on RNA concentration and diluted in water to 5 ng/ml
(RNA-equivalent). Because 286 transcripts were to be quantified
using 96.96 Dynamic Arrays (Fluidigm), each diluted cDNA
sample was split into 4 parts. The first part was used to check 18S
expression level homogeneity using ABI Prism 7900HT (Applied
Biosystems) to ensure good quality reverse transcription step. The
3 other parts were dedicated to target amplification for Biomark
Dynamic Arrays (Fluidigm). Inventoried TaqMan assays (Applied
Biosystems) were pooled into 3 separate sets (A, B, C), each using
96 probe and primers pairs, to a final concentration of 0.26 for
each of the 96 assays. Each set included GUSB as main reference
gene. 18S was included in set A. To increase sensitivity, a
multiplexed preamplification process was performed for each pool
on every 1.25 ml cDNA using 14 cycle cDNA preamplification step
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(95uC for 15 s and 60uC 4 min) and Taqman PreAmp Master Mix
(Applied Biosystems) in a standard PCR thermocycler. To check
reproducibility and test normalization approaches a sample
calibrator made of the cDNA from the same AT biopsy total
RNA sample was included in each plate for each of the 3 assay
pools.
Quantitative PCR. Preamplified cDNA was diluted 1:5 in
10 mmol/L Tris, 1 mmol/L EDTA. Diluted cDNA (2.25 ml) was
added to 2.5 ml Taqman Universal PCR Master Mix (Applied
Biosystems) and 0.25 ml GE Sample Loading Reagent (Fluidigm).
In a separate tube, 3.5 ml of Taqman Assay was added to 3.5 ml
Sample Loading Reagent. Five ml cDNA samples were loaded into
the sample inlet wells, and 5 ml assay samples were loaded into
assay detector inlets. For each plate, 1 well was loaded with H20 as
control for contamination and 1 well was loaded with the
calibration sample. The chip was primed and placed into the
NanoFlex Integrated fluidic circuit controller where 8 nl of cDNA
and 1 nl of Assay were mixed. Real time PCR analysis was
completed on the BioMark System (Fluidigm).
Data processing. Raw data obtained from the system’s
software using the default global threshold setting (BioMark Real-
time PCR Analysis V2.1.1, Fluidigm) were checked using the
graphical representation of the plate layout. Among the 414720
reactions investigated, 23 were rejected due to bubbles or instable
ROX signal. All amplification curves were displayed for each well
of the calibrator sample. When threshold for cycle did not meet
quality criteria (i.e. threshold set in the linear phase of the
amplification curve instead of the exponential phase), threshold
value was set manually and the analysis parameters were changed
to auto detector function for the corresponding gene and all the 15
Dynamic Arrays from the same set of genes. Wells with very high
(.30) or absent (999) endogenous Ct resulted in exclusion of 10
genes with too low or inconsistent expression level. Based on data
from the calibrator sample, 3 other genes with.20% outliers were
removed from the analysis. This resulted in 271 gene transcripts
with good quality expression data. Missing data were implemented
using k nearest neighbour methods.
Optimal normalization method of adipose tissue gene
expression. Different methods were assessed for real time
qPCR data normalization. The simplest one is based on the 22DCt
method [22] using an internal single reference gene. The use of a
reference gene depends on both tissue and cell type as well as the
experimental conditions. In order to capture the best control gene
for the study of human subcutaneous AT gene expression, we
previously measured the mRNA levels of 32 potential reference
genes by RT-qPCR using TaqMan Human Endogenous Control
Plate (Applied Biosystems) and the ABI Prism 7900HT Sequence
Detection System (Applied Biosystems) on cDNA obtained from
total RNA of 3 AT samples collected at each step of the program
(see below) from 6 obese individuals representing 6 of the different
European investigation centers (data not shown). A gene
expression normalization factor was calculated using the analysis
software Data Assist (Applied Biosystems) that uses the geNorm
algorithm [47]. The b-glucuronidase (GUSB) transcript proved the
best reference regarding the stability of mRNA level at different
body weights and fat mass, and across replicate samples.
Accordingly, in experiments including AT samples from lean,
obese and weight-reduced individuals, GUSB also proved the best
reference gene (data not shown). Consequently, GUSB was
included in the 286 genes to be investigated. It is to be noted
that among the 32 so-called house-keeping genes tested, four,
ribonuclease P/MRP subunit (POPP4), translation initiation factor
eIF-2B subunit a (EIF2B1), proteasome 26S subunit ATPase 4
(PSMC4) and glyceraldehyde-3-phosphate dehydrogenase (GAP
DH) were selected as targets of interest and included in the list of
transcripts to be quantified. Thus, they do not represent ap-
propriate reference genes.
Global normalization approaches have proven efficient for
microarray data. These methods use the whole data set. Large
scale data normalization algorithms such as rank-invariant and
quantile processes were tested as potential alternatives to the
reference gene method [21]. Both assume that the expression level
of the majority of the genes does not change. Of interest here,
quantile normalization is dedicated to correct for inter-plate
variations. Figure S2a shows the coefficient of variation for the 4
normalization methods compared to the raw dataset applied to the
calibration sample assayed in the 48 plates. The quantile and rank-
invariant methods were compared to the 22DCt calculation using
the eukaryotic ribosomal protein 18S (18S), or GUSB as reference.
When compared to non-normalized data, the quantile and rank-
invariant methods did not improve variability while using 18S
greatly increased variability. The best performance was obtained
with GUSB. All of the 4 methods tested provided similar results
when applied to the whole data set for all samples (Figure S2b).
Altogether, using GUSB appeared as the best process of
normalizing these large scale data. Moreover, the relative
expression level of this gene is similar across the 3 datasets (Figure
S2c).
DNA extraction and genotyping
Genomic DNA was extracted from the buffy coats with a
salting out method. Genomic and amplified DNA samples were
quality-checked, quantified and normalized to approximately
100 ng/ml and 2.0 mg before genotyping. High throughput SNP
genotyping was carried out using the Illumina iScan Genotyping
System (Illumina, San Diego, CA, USA). Seven hundred forty
eight individuals were genotyped using the Illumina 660W-Quad
SNP chip. SNP genotyping was done in accordance with
manufacturer’s protocols. The Integrated mapping information
is based on NCBI’s build 37. The coding sequences were
investigated 15 kb downstream and 10 kb upstream. All SNP
with a genotype frequency $95% and in Hardy-Weinberg
equilibrium (P.0.05) were selected for further analyses. Among
3965 SNPs related to 252 genes, 2953 SNPs remained after data
filtering.
Statistical analysis
Exploratory and descriptive analyses. The R software
(v2.11.0) was used for all statistical analyses. To normalize
variance, skewed clinical data were logged and gene expression
data were log2 transformed. One-way ANOVA was used for
analysis of total RNA extraction optimization data. In order to
obtain a global overview of the dataset principal component
analysis was performed as a first step in the data analysis. PLS-DA
was used to find the relationship between gene expression profiles
and phenotypic features [48].
Shapiro-Wilk distribution normality and Bartlett’s test variance
homogeneity, which incorporate within-subject and between-
subject variation, were applied to all gene expression data. A
linear mixed effect model, including fixed effects as sex and
metabolic syndrome status and introducing centre as random
effect, was used as the model basis (nlme package) [49]. Tukey
HSD was used as a post-hoc test. Supplementary factors are
specified and the linear mixed effect model regression equations
displayed in the legend of the tables. Genotype frequency and
Hardy-Weinberg equilibrium were tested using SNP assoc
package. Genetic association to gene expression was tested using
the SimHap package. The effect of sex was tested using chi2 test
Determinants of Human Fat Gene Expression
PLOS Genetics | www.plosgenetics.org 10 September 2012 | Volume 8 | Issue 9 | e1002959
and Fisher’s exact test. A Benjamini-Hochberg procedure [50] was
used to control the false discovery rate at 5% with the multtest
package (mt.rawp2adjp).
Gaussian Graphical Model network analysis. Two asso-
ciation networks were constructed using Gaussian Graphical
Models (GGM) [51] to represent the relationships between clinical
variables and the male and female baseline gene sets. An
intertwined, sparse LASSO (least absolute shrinkage and selection
operator) approach [52], which is able to handle large-scale data
and implemented in the R package simone [53], was employed to
ensure that the networks were inferred based on the assumption
that common functionality exists in both men and women. This
assumption is integrated in the GGM by means of a covariance
matrix that mixes the gender-specific covariance and the global
covariance over men and women together. The networks were set
to a density, the number of edges in the network divided by the
number of pairs of vertices (i.e. the number of possible edges), of
15%, which corresponds approximately to the maximum number
of edges to obtain a readable network. Dependency networks were
built using partial correlations as a measure of dependency and an
undirected GGM where the variables are connected if and only if
their partial correlation is significantly non zero. Unlike pairwise
measure of associations, such as Pearson correlation coefficients,
partial correlation provides a stronger criterion for dependency by
adjusting for confounding effects, and thus removes spurious
associations to a large extent. This is useful in order to integrate
multiple layers of information, as it filters out false positives by
discovering only high confidence direct interactions.
To study the dietary intervention, two networks were inferred to
model the relationships between log scaled ratios from baseline to
the end of LCD and from baseline to the end of WMD. A sparse
LASSO inference method, as implemented in the R package
simone [52], was used with the ‘‘AND’’ policy, which tends to
produce less false positive edges, and a 15% network density
constraint. The co-expression pattern networks were laid out using
the network analysis package Gephi (gephi.org) with the Fruchter-
man Reingold algorithm [54].
Supporting Information
Figure S1 Optimization of human adipose tissue total RNA
extraction. (a) Relation between adipose tissue weight and total
RNA amount. n=84. (b) Comparison of different adipose tissue
preparation and storage conditions (black bars, after 1 month
storage; open bars, after 1 year storage) on total RNA recovery :
immediate storage at 280uC (280uC), flash-freezing in liquid
nitrogen and storage at 280uC (N2), overnight incubation in
RNAlater RNA Stabilization Reagent (Qiagen) at 4uC and storage
at 280uC (RNA later), storage at 280uC in QIAzol Lysis Reagent
(QIAzol) and storage at 280uC after homogeneization in QIAzol
Lysis Reagent with ultra-Turax (Turax). n=4. (c) Effect of
duration of storage at 280uC on adipose tissue total RNA yield
with comparison of flash-freezing in liquid nitrogen before storage
(black bars) and storage in QIAzol Lysis Reagent (open bars).
n=3–15.
(TIF)
Figure S2 Validation of quantitative PCR normalization
methods. (a) Comparison of methods applied to the calibration
sample. Bar charts represent coefficient of variation of calibration
sample gene expression level using 4 different normalization
methods compared to the raw dataset. The quantile and rank-
invariant methods are compared to the delta Ct calculation with
the 18S, or GUSB, data from the corresponding preamplified
cDNA. (b) Comparison of methods applied to the whole dataset.
Bar charts represent coefficient of variation of calibration sample
gene expression level using 4 different normalization methods
compared to the raw dataset. The quantile and rank-invariant
methods are compared to the delta Ct calculation with the 18S, or
GUSB data from the corresponding preamplified cDNA. (c) GUSB
expression levels shown as cycle threshold across the 3 datasets (A,
B and C) related to the 3 groups of 96 genes of interest (95 genes
plus GUSB) respectively.
(TIF)
Figure S3 Flow chart of DiOGenes analyses. Individuals from
group A are those with gene expression data available at baseline,
at the end of the 8-week calorie restriction and at the end of the
26-week weight follow-up. Individuals from group B are those with
gene expression data available only at baseline. BAS: baseline,
LCD: low calorie diet, WMD: weight maintenance diet. MS:
metabolic syndrome. BMI: body mass index. SNP: single
nucleotide polymorphism. Dotted arrows represent the statistical
analyses output.
(TIF)
Figure S4 Exploratory analyses of adipose tissue gene expression
from 515 subjects at baseline. (a) Plots of PLS-DA (Partial Least
Square-Discriminant Analysis) used for explaining differences
between 180 men (black circles) and 335 women (open circles)
(R2 = 0.257; Q2= 0.259). (b) Plot of PLS-DA used for explaining
differences between 309 non-metabolic syndrome (grey triangles)
and 206 metabolic syndrome (black squares) individuals
(R2 = 0.270; Q2= 0.106).
(TIF)
Figure S5 Topology of the male and female networks at
baseline. A dependency network was constructed from selected
gene expression and bio-clinical data from 180 men (a) and 335
women (b). Each node is a gene or a bio-clinical parameter. Node
degree is indicated with node size. Node color indicates
betweenness centrality metric that measures how often a node
appears on shortest paths between nodes in the network, from red
(high level) to green (low level). Betweenness centrality indicates
influential nodes for highest values. The variables are connected
by an edge only if their partial correlation is significantly nonzero.
Edge thickness is proportional to the strength of correlation. Edge
color indicates positive (red) or negative (light green) correlation.
The orange ellipse indicates the lipogenic module.
(TIF)
Table S1 Methods for extraction of total RNA from human
adipose tissue. *: 0, degradation; 1, low purity with spurious
genomic DNA; 11, high quality based on 28 to 18S RNA ratio and
absence of genomic DNA. RNA quality was checked using
ethidium bromide stained agarose gels. Concentration was
determined using Nanodrop spectrophotometer. Values refer to
means 6 SEM.
(DOCX)
Table S2 Clinical and biological parameters of obese individuals
before dietary intervention. Values refer to means 6 SEM. *** p
,0.001, ** p,0.01, * p,0.1 between non-metabolic syndrome
(non-MS) and metabolic syndrome (MS) subjects as estimated using
linear mixed effect model ran separately for men and women with
metabolic syndrome status as fixed and centre as random effect. BMI
is body mass index [weight (kg)/height2 (m)]. SBP and DBP are,
respectively, systolic and diastolic blood pressures. HDL-C and LDL-
C are, respectively, high and low density lipoprotein-cholesterol. The
homeostatic model assessment (HOMA-IR) is method to assess
insulin resistance [glucose (mM) x insulin (mU/l)/22.5].
(DOCX)
Determinants of Human Fat Gene Expression
PLOS Genetics | www.plosgenetics.org 11 September 2012 | Volume 8 | Issue 9 | e1002959
Table S3 Description of target genes. Cell marker column refers
to the adipose tissue cell type.
(DOCX)
Table S4 Genes with opposite regulation during low calorie diet
and weight maintenance diet phases. A linear mixed effect model
was run separately for men and women with time point (clinical
investigation day, CID), weight at baseline and weight change as
fixed effect. Centre and subject were entered as random effect.
Diet was included as supplementary fixed effect in the model
investigating genes during weight maintenance diet. The regres-
sions equations tested without and with weight are displayed
below:
$ : Yidfckl~m zWeightfð ÞzCIDczCentrek=Subjectlz
eidfckl, with eidfckl&N(0,s2)
: Yidfckl~mzDietd zWeightfð ÞzCIDcz
Centrek=Subjectlzeidfckl, with eidfckl&N 0,s
2
! "
Y is the log2 expression value for gene i, in subject l, and centre k.
The random term e represents the random error that was assumed
to be normally distributed. The Tukey HSD was used as post-hoc
test. The Benjamini-Hochberg procedure was used to control for
multiple testing. Only significant genes common to men and
women and weight-independent genes were selected. *: Values
refer to median mRNA level fold change from 311 subjects (107
men, 204 women).
(DOCX)
Table S5 Genes regulated at the end of the dietary intervention.
A linear mixed effect model was ran separately for men and
women with weight, clinical investigation day (CID) and diet as
fixed, and centre and subject as random effect. The regressions
equations tested without and with weight are displayed below:
Yidfckl~mzDietd zWeightfð ÞzCIDczCentrek=Subjectlz
eidfckl, with eidfckl&N(0,s2)
Y is the log2 expression value for gene i, in subject l, and centre k.
The random term e represents the random error that was assumed
to be normally distributed. The Tukey HSD was used as post-hoc
test. The Benjamini-Hochberg procedure was used to control for
multiple testing. Only significant genes common to men and
women and weight-independent genes are shown. *: Values refer
to median mRNA level fold change from 311 subjects (107 men,
204 women).
(DOCX)
Table S6 Markers of weight loss and weight regain during the
weight maintenance diet phase. *: Values refer to ratio of mean
mRNA level fold change from CID2 to CID3 between 31 women
who gained (Regain) and 29 who lost (Loss) at least 50% of the
weight lost during calorie restriction. £: Values refer to median
mRNA level fold change between CID2 and CID3 in 31 women
who gained at least 50% of the weight lost during calorie
restriction. 1: Values refer to median mRNA level fold change
between CID2 and CID3 in 29 women who continued to lose at
least 50% of the weight lost during calorie restriction. A linear
mixed effect model was ran separately for men and women with
weight, CID and diet as fixed, and centre and subject as random
effect. The regression equation tested is displayed below:
CID3=CID2Expressionidehkl~mzDietdz
CID2=CID1Expressionez
GrouphzCentrekz
eidehkl with eidehkl&N 0,s2
! "
CID3/CID2Expression is the log2 expression value for gene i, in
subject l, and centre k. The random term e represents the random
error that was assumed to be normally distributed. The Tukey
HSD was used as post-hoc test. The Benjamini-Hochberg
procedure was used to control for multiple testing. CID1, CID2
and CID3 are, respectively, clinical investigation days at baseline,
after the 8-week calorie restriction and after the 26-week weight
maintenance diet.
(DOCX)
Table S7 Sexual dimorphism of adipose tissue gene expression
in 515 obese individuals. A linear mixed effect model was ran with
gender as fixed and centre as random effect. The regression
equation tested without and with fat mass (% of body weight) is
displayed below:
Yiskl~mzGenders z%Fat Masssð Þz
Centrekzeiskl with eiskl&N(0,s2)
Y is the log2 expression value for gene i, in subject l, and centre k.
The random term e represents the random error that was assumed
to be normally distributed. The Tukey HSD was used as post-hoc
test. The Benjamini-Hochberg procedure was used to control for
multiple testing. Only genes consistently significant among all
phases of the dietary intervention were considered (see Figure S3).
Bold indicates genes which sexual dimorphism is influenced by fat
mass. *: Values refer to ratio of mean mRNA levels at baseline
between 180 men and 335 women.
(DOCX)
Table S8 Differential adipose tissue gene expression according
to presence and absence of metabolic syndrome in 515 obese
individuals. P-value between non-metabolic syndrome and
metabolic syndrome subjects as estimated using linear mixed
effect model ran separately for men and women with metabolic
syndrome status as fixed and centre as random effect, Tukey HSD
as post-hoc test and Benjamini-Hochberg to control for multiple
testing. The regression equation tested is displayed below:
Yijkl~mzMSjzCentrekzeijkl with eijkl&N(0,s2)
Y is the log2 expression value for gene i, in subject l, and centre k.
The random term e represents the random error that was assumed
to be normally distributed. MS and non-MS are, respectively,
subjects categorized according to the occurrence of metabolic
syndrome [11], or not. The Tukey HSD was used as post-hoc test.
*: Values refer to ratio of mean mRNA levels between metabolic
syndrome (92 men, 114 women) and non-metabolic syndrome (88
men, 221 women) subjects at baseline (see Figure S3).
(DOCX)
Table S9 Obesity-related genes in women along the dietary
intervention. Values refer to ratio of mean mRNA level from
highest and lowest BMI decile subjects in 204 women from group A.
CID1, CID2 and CID3 are, respectively, clinical investigation days
at baseline, after the 8-week calorie restriction and after the 26-week
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weight maintenance diet. A linear mixed effect model was run with
BMI as fixed and centre as random effect at each time point. Diet
was entered as supplementary fixed effect in the model investigating
genes during weight maintenance diet. The regressions equations
tested without and with change in BMI are displayed below:
at CID1 and CID2 : Yikl~mzBMIlzCentrekz
eikl with eikl&N(0,s2)
at CID3 : Yidkl~mzDietdzBMIlz
Centrekzeidkl with eidkl&N(0,s2)
Y is the log2 expression value for gene i, in subject l, centre k and
Diet d. The random term e represents the random error that was
assumed to be normally distributed. The Benjamini-Hochberg
procedure was used to control for multiple testing.
(DOCX)
Table S10 Genes selected for network analysis at baseline.
(DOCX)
Table S11 Lipogenic and glycolytic genes selected for network
analysis during dietary intervention. Genes were selected as part of
the lipogenic module observed in Figure S5 with other genes
encoding proteins involved in lipogenesis or glucose metabolism.
(DOCX)
Table S12 SNPs showing associations with adipose tissue gene
expression at baseline. Gene expression data were log transformed.
Association of 2953 SNPs with gene expression was tested at
baseline in 422 individuals (148 men and 274 women) using a
linear mixed model with gender (and BMI) as fixed and centre
(and diet) as random effect assuming a linear log-additive allele-
dose effect with each SNP coded 0, 1 and 2 according to the
number of minor alleles an individual carries (0 =wild-type,
1 = heterozygote, 2 = homozygote). The regression equation
displayed below was tested without then with BMI:
Yijkl~mzGenderg zBMI CID1ið ÞzSNPsjz
Centrekzeijgk, with eijgk&N(0,s2):
Y is the log2 expression value for gene i, in subject l, and centre k.
The random term e represents the random error that was assumed
to be normally distributed. Gender difference between genotype
distribution was investigated using a chi2 test to test the
independence between the people belonging to the individual
and the value criteria. For regression expected values .5, the non-
parametric Fisher’s exact test was used. The Benjamini-Hochberg
procedure was used to control for multiple testing. CID1 is clinical
investigation day at baseline.
(DOCX)
Table S13 Significativity of SNP association with adipose tissue
gene expression along the dietary program. To test the validity of
the association of the SNPs significant at CID1 with gene expression
along the dietary program, a linear mixed model was ran with gene
expression data at CID1, CID2 and CID3 according to the
regression equations displayed below. Each SNP was evaluated
under a log additive model assuming a linear allele-dose effect
(0=Wild-type, 1 = heterozygote, 2= homozygote). The regression
equations were tested without then with BMI.
# : Yijkl~~mzGendergz BMI CID1CID2ið ÞzSNPsjz
Centrekzeijgk with eijgk&N 0,s2
! "
,
n~414 145 men, 269 womenð Þ:
## : Yijkl~mzDietlzGendergz
BMI CID1CID2CID3ið ÞzSNPsjz
Centrek=Subjectiz
eijgkl with eijgkl&N 0,s2
! "
,
n~261 88 men, 173 womenð Þ:
# # # : Yijkl~mzDietlzGenderg
z BMI CID1CID3ið ÞzSNPsjz
Centrekzeijgkl with eijgkl&N(0,s2),
n~269 91 men, 178 womenð Þ:
Y is the log2 expression value for gene i, in subject l, and centre k.
The random term e represents the random error that was assumed
to be normally distributed. The Benjamini-Hochberg procedure
was used to control for multiple testing. CID1, CID2 and CID3 are,
respectively, clinical investigation days at baseline, after the 8-week
calorie restriction and after the 26-week weight maintenance diet.
(DOCX)
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